S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
NASDAQ:TRNS

Transcat (TRNS) Stock Price, News & Analysis

$104.71
-3.84 (-3.54%)
(As of 04/17/2024 ET)
Today's Range
$104.14
$109.44
50-Day Range
$103.12
$113.50
52-Week Range
$74.89
$115.41
Volume
48,434 shs
Average Volume
37,953 shs
Market Capitalization
$924.59 million
P/E Ratio
80.55
Dividend Yield
N/A
Price Target
$114.00

Transcat MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
8.9% Upside
$114.00 Price Target
Short Interest
Healthy
1.73% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.40mentions of Transcat in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$900,023 Sold Last Quarter
Proj. Earnings Growth
54.41%
From $1.36 to $2.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.34 out of 5 stars

Computer And Technology Sector

375th out of 587 stocks

Instruments To Measure Electricity Industry

6th out of 8 stocks

TRNS stock logo

About Transcat Stock (NASDAQ:TRNS)

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.

TRNS Stock Price History

TRNS Stock News Headlines

Transcat (NASDAQ:TRNS) Receives Buy Rating from HC Wainwright
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Transcat Stock: Time To Recalibrate
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Transcat Operating Chief Mark Doheny to Step Down
Transcat COO Mark Doheny To Step Down; Mike West To Succeed
Craig-Hallum Keeps Their Buy Rating on Transcat (TRNS)
See More Headlines
Receive TRNS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Transcat and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/29/2024
Today
4/17/2024
Next Earnings (Estimated)
5/27/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Industry
Instruments to measure electricity
Sub-Industry
N/A
Current Symbol
NASDAQ:TRNS
Employees
1,030
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$114.00
High Stock Price Target
$124.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+9.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$10.69 million
Pretax Margin
5.45%

Debt

Sales & Book Value

Annual Sales
$230.57 million
Cash Flow
$2.72 per share
Book Value
$13.18 per share

Miscellaneous

Free Float
8,458,000
Market Cap
$923.00 million
Optionable
Not Optionable
Beta
0.59
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

TRNS Stock Analysis - Frequently Asked Questions

Should I buy or sell Transcat stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Transcat in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRNS shares.
View TRNS analyst ratings
or view top-rated stocks.

What is Transcat's stock price target for 2024?

2 equities research analysts have issued 1 year target prices for Transcat's stock. Their TRNS share price targets range from $110.00 to $124.00. On average, they predict the company's share price to reach $114.00 in the next twelve months. This suggests a possible upside of 8.9% from the stock's current price.
View analysts price targets for TRNS
or view top-rated stocks among Wall Street analysts.

How have TRNS shares performed in 2024?

Transcat's stock was trading at $109.33 at the start of the year. Since then, TRNS shares have decreased by 4.2% and is now trading at $104.71.
View the best growth stocks for 2024 here
.

When is Transcat's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our TRNS earnings forecast
.

How were Transcat's earnings last quarter?

Transcat, Inc. (NASDAQ:TRNS) issued its quarterly earnings results on Monday, January, 29th. The scientific and technical instruments company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. The scientific and technical instruments company earned $65.17 million during the quarter, compared to the consensus estimate of $63.36 million. Transcat had a trailing twelve-month return on equity of 9.32% and a net margin of 4.16%.

What ETFs hold Transcat's stock?

ETFs with the largest weight of Transcat (NASDAQ:TRNS) stock in their portfolio include Invesco DWA SmallCap Momentum ETF (DWAS).AdvisorShares Dorsey Wright Micro-Cap ETF (DWMC).

What is Lee Rudow's approval rating as Transcat's CEO?

20 employees have rated Transcat Chief Executive Officer Lee Rudow on Glassdoor.com. Lee Rudow has an approval rating of 69% among the company's employees.

What other stocks do shareholders of Transcat own?
Who are Transcat's major shareholders?

Transcat's stock is owned by a number of retail and institutional investors. Top institutional investors include Wealth Enhancement Advisory Services LLC (0.83%) and Annex Advisory Services LLC (0.10%). Insiders that own company stock include Carl E Sassano, Charles P Hadeed, Craig D Cairns, Gary J Haseley, James M Jenkins, Lee D Rudow, Michael W West, Richard J Harrison and Scott Deverell.
View institutional ownership trends
.

How do I buy shares of Transcat?

Shares of TRNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TRNS) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners